Global Cardio Oncology Registry
Key facts
- Where
- Weston, United StatesSee the site
Where in United States
- Cleveland Clinic FloridaWeston, United StatesContact: Diego Sadler, MD FACCTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The Cleveland Clinic
- Trial code
- NCT05598879
- Record updated
- 12 May 2026
- Original description
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.Read full original descriptionShow less
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
Inclusion: New cardio-oncology consultation for breast cancer patients, or; New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or; New cardio-oncology consultation for acute or chronic leukemia patients, or; New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or; New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation; All patients have to be 18 years old or older.
Exclusion: Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators; Minors less than 18 years old; Inability or unwillingness to consent to participate.